Recent developments in obesity management have been revolutionized by introducing novel glucagon-like peptide-1 (GLP-1) based drugs, such as semaglutide and tirzepatide
Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms
If any side effects persist for more than a few weeks or become severe, reach out to your healthcare provider for further advice
One innovative therapy we offer is the Ozempic shot, a GLP-1 receptor agonist originally developed to manage type 2 diabetes and now widely recognized for its remarkable effectiveness in promoting weight loss
Another GoF variant, A316T, shows a 2-fold increase in cAMP accumulation ( 2+ mobilization (which is essential for insulin secretion)
Quick Facts: Retatrutide at a Glance Definition: Retatrutide (LY3437943) is an investigational peptide that activates three metabolic receptors GLP-1, GIP, and glucagon through one molecule